Thyroid Disorders in Malaysia: A Nationwide Multicentre Study
NCT ID: NCT02190214
Last Updated: 2016-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2498 participants
OBSERVATIONAL
2014-08-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
General hypotheses:
The prevalence of thyroid disorders in Malaysia is 10% for hypothyroidism and 2% for hyperthyroidism Hypo- and hyperthyroidism is associated with iodine status in our population There are different susceptibility gene for autoimmune thyroid disorder in different ethnicity in our population
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Prognostic Effects of Thyroid Abnormalities in Patients With Acute Coronary Syndrome.
NCT06579014
Study on the Relationship Between Iodine Nutrition and Thyroid Diseases in the Elderly
NCT05716191
Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism
NCT02090907
Non-immune Related Hypothyroidism in Iodine Sufficient Area
NCT03180892
the Effect of Universal Salt Iodization on Thyroid Diseases
NCT01838629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Blood will be analyzed for thyroid function (thyroxine, triiodothyronine and thyroid stimulating hormone), autoantibodies (anti-thyroperoxidase and anti-thyroglobulin). Urine will be analyzed for urinary iodine.
Those diagnosed with autoimmune thyroid disorders with strong family history of thyroid disorders (multiplex multi-generation family involvement) will have their blood sent for whole exome sequencing and linkage analysis done to identify possible susceptible gene for autoimmune thyroid disorders
Respondents detected to have hypo- or hyper- and subclinical hypo- or hyperthyroidism will be referred to their nearest health centre for further evaluation and treatment appropriate for their condition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Malaysian citizen
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Malaysian Endocrine and Metabolic Society
OTHER
National University of Malaysia
OTHER
University of Malaya
OTHER
IMU University, Malaysia
OTHER
International Islamic University Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Mohamnmad Arif Shahar
Assist Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nor Azmi Kamaruddin, MBBS, MMed
Role: PRINCIPAL_INVESTIGATOR
National University of Malaysia
Norlela Sukor, MMed, Phd
Role: PRINCIPAL_INVESTIGATOR
National University of Malaysia
Norhanita Othman
Role: PRINCIPAL_INVESTIGATOR
National University of Malaysia
Johari Ali
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Shirenee Vethakkan
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Siew Kim Kwa
Role: PRINCIPAL_INVESTIGATOR
IMU University, Malaysia
Kuck Meng Chong, MD
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Lecthuman Ramanathan
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Hussein Zanariah
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Nurain Mohd Noor
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Norhaliza Mohd Ali
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Norhayati Yahya
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Nor Azizah Aziz
Role: PRINCIPAL_INVESTIGATOR
Malaysian Endocrine and Metabolic Society
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MyEndo-Thyroid
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.